PV Bulletin

TGA seizes illegal peptides and steroids linked to social media influencer

The TGA, assisted by NSW Police, seized over $120,000 of illicit products from two homes in NSW. This action is part of a crackdown on unapproved therapeutic goods sold online.

Primary source: Safety monitoring and information

PV Impact Brief

Urgency: HighConfidence: high

What changed

The TGA executed search warrants resulting in the seizure of illicit peptide and steroid products.

Why it matters

This enforcement action highlights the TGA's commitment to regulating the importation and sale of unapproved therapeutic goods, ensuring consumer safety and compliance with Australian laws.

Action needed

Regulatory intelligence workflows should address this enforcement action as part of ongoing compliance monitoring regarding the sale and promotion of unapproved therapeutic goods.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Country Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 17, 2026

Full briefing

Practical implication

Regulatory intelligence workflows should address this enforcement action as part of ongoing compliance monitoring regarding the sale and promotion of unapproved therapeutic goods.

The Therapeutic Goods Administration (TGA) has seized more than $120,000 worth of illicit peptide and anabolic steroid products linked to a social media influencer in New South Wales. This operation, executed on August 4, 2026, included products like retatrutide and CJC-1295, and serves as a warning against unlawful activities involving unapproved therapeutic goods online.

What changed: The TGA executed search warrants resulting in the seizure of illicit peptide and steroid products.

Why it matters: This enforcement action highlights the TGA's commitment to regulating the importation and sale of unapproved therapeutic goods, ensuring consumer safety and compliance with Australian laws.

Practical implication: Regulatory intelligence workflows should address this enforcement action as part of ongoing compliance monitoring regarding the sale and promotion of unapproved therapeutic goods.

View original source

  • Source: TGA Safety Alerts - News and events
  • Published at source: 2026-08-17T22:16:00.000Z
  • Discovered by monitor: 2026-08-17T22:23:44.567Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signals#Other#Australia#Source-ingestion#Regulator-monitor#Tga.gov.au

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Urgent Withdrawal of Reusable da Vinci S and Si Instruments Due to Cable Degradation

Urgency: High

Healthcare facilities must isolate the affected instruments and notify Intuitive Surgical for returns while preparing for potential delays in surgical procedures due to instrument replacements.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward
publicANSM · France · Updated Sep 7, 2026Translated From French

Injunction No. 2026-DM-031-INJ Regarding Ortho Partner Establishment in Montreuil

Urgency: High

Establish compliant storage conditions for medical devices and set up a non-conformity management system within 3 months.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward